TAT Technologies director reports 50,000 stock options
TAT Technologies Ltd director Malka Amos reported her initial holdings as an insider.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
TAT Technologies Ltd director Malka Amos reported her initial holdings as an insider. The filing shows she holds stock options to acquire 50,000 Ordinary Shares at an exercise price of 29.9300 per share, expiring on March 20, 2032.
According to the vesting schedule, 37,500 of these options vest on March 20, 2026, with the remaining options vesting in installments of 9,375 every three months from June 20, 2026 through March 20, 2029, subject to her continued service. The filing also indicates she currently holds 0 Ordinary Shares directly, so her exposure is entirely through these unexercised options.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Ordinary Shares | -- | -- | -- |
Footnotes (1)
- F1. The stock options were granted on March 20, 2025. 37,500 options vest on March 20, 2026; and the remaining options vest in installments of 9,375 every three months beginning on June 20, 2026 through March 20, 2029, subject to the Reporting Person's continued services to the Issuer through each such vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
